Literature DB >> 22282053

Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

Judith H Aberle1, Karin Stiasny, Michael Kundi, Franz X Heinz.   

Abstract

It is well established that immunologic memory generated early in life can be maintained into old age and mediate robust anamnestic antibody responses. Little is known, however, about the initiation of memory B cells in the elderly. We have conducted a prospective analysis of the quantities and functionalities of antigen-specific B cell responses and its association with the functional helper CD4(+)T cell responses. The ability of naïve B cells from old (60-80 years) and young (20-31 years) humans to establish functional memory was examined following primary and booster vaccination with an inactivated-virus vaccine against tick-borne encephalitis. Our data show that the number of antigen-specific memory B cells generated during primary vaccination was ~3-fold lower in old than in young individuals. The maintenance and booster responsiveness of these memory B cells were not compromised, as evidenced by similar increases in specific memory B cell frequencies upon revaccination in old and young adults. In contrast, the Ab response mediated per memory B cell after revaccination was dramatically diminished in the elderly. Also, antigen-specific IL-2-positive CD4(+)T cell responses were strongly reduced in the elderly and displayed an excellent correlation with Ab titres. The data suggest that the dramatically lower antibody response in the elderly could only partially be accounted for by the reduced B cell numbers and was strongly correlated with profound functional defects in CD4 help.

Entities:  

Mesh:

Year:  2012        PMID: 22282053      PMCID: PMC3592966          DOI: 10.1007/s11357-011-9371-9

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  46 in total

Review 1.  Homeostasis and the age-associated defect of CD4 T cells.

Authors:  Susan Swain; Karen Clise-Dwyer; Laura Haynes
Journal:  Semin Immunol       Date:  2005-10       Impact factor: 11.130

Review 2.  Persistence of antibodies after vaccination against tick-borne encephalitis.

Authors:  Pamela Rendi-Wagner; Olaf Zent; Wolfgang Jilg; Annelie Plentz; Jiri Beran; Herwig Kollaritsch
Journal:  Int J Med Microbiol       Date:  2006-03-09       Impact factor: 3.473

3.  Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.

Authors:  Alexandra Loew-Baselli; Eva-Maria Poellabauer; Borislava G Pavlova; Sandor Fritsch; Manuela Koska; Roman Bobrovsky; Ryszard Konior; Hartmut J Ehrlich
Journal:  Hum Vaccin       Date:  2009-08

4.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

Review 5.  Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up.

Authors:  Mats Haglund; Göran Günther
Journal:  Vaccine       Date:  2003-04-01       Impact factor: 3.641

Review 6.  The immunology of exceptional individuals: the lesson of centenarians.

Authors:  C Franceschi; D Monti; P Sansoni; A Cossarizza
Journal:  Immunol Today       Date:  1995-01

Review 7.  The effect of age on the cognate function of CD4+ T cells.

Authors:  Laura Haynes; Sheri M Eaton
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

8.  Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis.

Authors:  Aukse Mickiene; Alvydas Laiskonis; Göran Günther; Sirkka Vene; Ake Lundkvist; Lars Lindquist
Journal:  Clin Infect Dis       Date:  2002-08-20       Impact factor: 9.079

9.  CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly.

Authors:  Laura Haynes; Sheri M Eaton; Eve M Burns; Troy D Randall; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

10.  Immunogenicity of combined hepatitis A and B vaccine in elderly persons.

Authors:  Bernd Wolters; Ulrich Junge; Stefan Dziuba; Michael Roggendorf
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

View more
  15 in total

1.  Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Authors:  Julia Schwaiger; Judith H Aberle; Karin Stiasny; Bernhard Knapp; Wolfgang Schreiner; Ingrid Fae; Gottfried Fischer; Ondrej Scheinost; Vaclav Chmelik; Franz X Heinz
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

2.  Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis.

Authors:  Karin Stiasny; Judith H Aberle; Michael Keller; Beatrix Grubeck-Loebenstein; Franz X Heinz
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

3.  Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.

Authors:  Judith H Aberle; Julia Schwaiger; Stephan W Aberle; Karin Stiasny; Ondrej Scheinost; Michael Kundi; Vaclav Chmelik; Franz X Heinz
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

4.  Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection.

Authors:  Alexander J McAuley; Bevan Sawatsky; Thomas Ksiazek; Maricela Torres; Miša Korva; Stanka Lotrič-Furlan; Tatjana Avšič-Županc; Veronika von Messling; Michael R Holbrook; Alexander N Freiberg; David W C Beasley; Dennis A Bente
Journal:  NPJ Vaccines       Date:  2017-03-13       Impact factor: 7.344

5.  Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination.

Authors:  Maximilian Koblischke; Maria S Mackroth; Julia Schwaiger; Ingrid Fae; Gottfried Fischer; Karin Stiasny; Franz X Heinz; Judith H Aberle
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

6.  Onset of immune senescence defined by unbiased pyrosequencing of human immunoglobulin mRNA repertoires.

Authors:  Florian Rubelt; Volker Sievert; Florian Knaust; Christian Diener; Theam Soon Lim; Karl Skriner; Edda Klipp; Richard Reinhardt; Hans Lehrach; Zoltán Konthur
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.

Authors:  Roland Züst; Hongping Dong; Xiao-Feng Li; David C Chang; Bo Zhang; Thavamalar Balakrishnan; Ying-Xiu Toh; Tao Jiang; Shi-Hua Li; Yong-Qiang Deng; Brett R Ellis; Esther M Ellis; Michael Poidinger; Francesca Zolezzi; Cheng-Feng Qin; Pei-Yong Shi; Katja Fink
Journal:  PLoS Pathog       Date:  2013-08-01       Impact factor: 6.823

8.  Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals.

Authors:  Pontus Lindblom; Peter Wilhelmsson; Linda Fryland; Andreas Matussek; Mats Haglund; Johanna Sjöwall; Sirkka Vene; Dag Nyman; Pia Forsberg; Per-Eric Lindgren
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

9.  Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice.

Authors:  Krysta M Felix; Ivan A Jaimez; Thuy-Vi V Nguyen; Heqing Ma; Walid A Raslan; Christina N Klinger; Kristian P Doyle; Hsin-Jung J Wu
Journal:  Front Cell Infect Microbiol       Date:  2018-04-18       Impact factor: 5.293

10.  Strong interferon-gamma mediated cellular immunity to scrub typhus demonstrated using a novel whole cell antigen ELISpot assay in rhesus macaques and humans.

Authors:  Manutsanun Sumonwiriya; Daniel H Paris; Piyanate Sunyakumthorn; Tippawan Anantatat; Kemajittra Jenjaroen; Suchintana Chumseng; Rawiwan Im-Erbsin; Ampai Tanganuchitcharnchai; Suthatip Jintaworn; Stuart D Blacksell; Fazle R Chowdhury; Barbara Kronsteiner; Prapit Teparrukkul; Robin L Burke; Eric D Lombardini; Allen L Richards; Carl J Mason; James W Jones; Nicholas P J Day; Susanna J Dunachie
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.